Shopping Cart
Remove All
Your shopping cart is currently empty
AChE/BuChE-IN-5 (compound 5a) is a dual-target inhibitor with potent nanomolar inhibitory activity against acetylcholinesterase (AChE) (IC50=46.9 nM) and butyrylcholinesterase (BuChE) (IC50=3.5 nM). This compound is useful for Alzheimer's disease research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | AChE/BuChE-IN-5 (compound 5a) is a dual-target inhibitor with potent nanomolar inhibitory activity against acetylcholinesterase (AChE) (IC50=46.9 nM) and butyrylcholinesterase (BuChE) (IC50=3.5 nM). This compound is useful for Alzheimer's disease research. |
| Targets&IC50 | AChE:46.9 nM |
| In vitro | AChE/BuChE-IN-5 is a compound that inhibits acetylcholinesterase (AChE) with an IC50 of 46.9 nM and butyrylcholinesterase (BuChE) with the same IC50 value, showing greater efficacy compared to the known dual inhibitor Rivastigmine in animal models of Alzheimer's disease (AD). The compound exhibits a higher selectivity for BuChE over AChE, with a selectivity index (SI) of 0.07, indicating a stronger inhibitory effect on BuChE. |
| In vivo | AChE/BuChE-IN-5 (1 mg/kg, ip, 14 days) exhibits neuroprotective, antioxidant, and anti-apoptotic effects in an AD animal model. |
| Formula | C19H14N4O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.